Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription 05.10.2026 1 Am J Psychiatry 1 Exp Neurol 1 J Neural Transm (Vienna) 3 Mov Disord 1 Neurobiol Dis 2 Neurology 1 Neurosci Lett 1 Neuroscience 1 PLoS One 2 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Psychiatry

1. SIDDIQI SH, Klingbeil J, Webler R, Kratter IH, et al
   Convergent Network Localization of Brain Stimulation Targets for Trait Anxiety.
   Am J Psychiatry. 2026;183:785-796.
   PubMed         Abstract available
   
   

   
   Exp Neurol

2. KHUNDERYAKOVA NV, Pshenichnikova TV, Malkov AE, Bulgin IV, et al
   Systemic energy and neuroinflammatory disturbances in a lactacystin-induced rat model of Parkinson's disease.
   Exp Neurol. 2026;407:116035.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

3. HERO M, Papic E, Grozdanic N, Vuletic V, et al
   Continuous infusion therapy after deep brain stimulation in Parkinson's disease: indications, outcomes, and patient selection.
   J Neural Transm (Vienna). 2026 Sep 28. doi: 10.1007/s00702-026-03300.
   PubMed         Abstract available
   
   

   
   Mov Disord

4. 
   2026 International Congress of Parkinson's Disease and Movement Disorders.
   Mov Disord. 2026;41 Suppl 1:S1-S68.
   PubMed        
   
   
5. ASIMAKIDOU E, Avenali M, Aasly JO, Afshari M, et al
   Timing of Deep Brain Stimulation and Cognitive Trajectories in GBA1-Associated Parkinson's Disease.
   Mov Disord. 2026 Oct 1. doi: 10.1002/mds.70520.
   PubMed         Abstract available
   
   
6. LUTH T, Gabbert C, Kleinz T, Much C, et al
   alpha-Synuclein Seeding Discriminates Between LRRK2 G2019S Variant Carriers with and Without Parkinson's Disease.
   Mov Disord. 2026 Sep 28. doi: 10.1002/mds.70553.
   PubMed         Abstract available
   
   

   
   Neurobiol Dis

7. GREGORETTI SC, Eskow Jaunarajs KL, Scarduzio M
   Altered striatal acetylcholine dynamics in a model of Parkinson's disease and L-DOPA-induced dyskinesia.
   Neurobiol Dis. 2026 Oct 1:107636. doi: 10.1016/j.nbd.2026.107636.
   PubMed         Abstract available
   
   

   
   Neurology

8. LIU M, Yang T, Li L, Zhu J, et al
   Association of Skin Denervation With Brain Atrophy and Cognitive Impairment in Patients With Parkinson Disease.
   Neurology. 2026;107:e218583.
   PubMed         Abstract available
   
   
9. FABIANI G, Amarante DF
   The Fabulous Game of Parkinson Disease Biomarkers.
   Neurology. 2026;107:e218639.
   PubMed        
   
   

   
   Neurosci Lett

10. LIM HS, Park J, Lee W, Park G, et al
    Varlitinib attenuates neuroinflammation and dopaminergic neurodegeneration in experimental Parkinsonism.
    Neurosci Lett. 2026 Sep 30:138746. doi: 10.1016/j.neulet.2026.138746.
    PubMed         Abstract available
    
    

    
    Neuroscience

11. MOHAMMAD H, Singh A, Bansal D
    Identification of a shared blood-brain transcriptomic signature in Parkinson's disease using bioinformatic and network pharmacology approaches.
    Neuroscience. 2026 Oct 2:S0306-4522(26)00662.
    PubMed         Abstract available
    
    

    
    PLoS One

12. CALLIZOT N, Culley G, Flower G, Rouviere L, et al
    AZP2006 in Parkinson's disease models: A promising new neuroprotective treatment involving lysosomal homeostasis and the Progranulin/Prosaposin complex.
    PLoS One. 2026;21:e0359269.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

13. HELMICH RC, van den Berg KRE
    The good, the bad, and the ugly: A three-circuit model of Parkinson's tremor.
    Rev Neurol (Paris). 2026 Oct 1:S0035-3787(26)00605.
    PubMed         Abstract available
    
    
14. CHEN BS, Sandlin DS, Biousse V
    The eyes and Parkinsonian syndromes.
    Rev Neurol (Paris). 2026 Sep 30:S0035-3787(26)00607.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum